Strides Pharma Science Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Public

  • Employees
  • 4,050

Employees

  • Stock Symbol
  • STAR

Stock Symbol

  • Investments
  • 55

  • Share Price
  • $10.48
  • (As of Thursday Closing)

Strides Pharma Science General Information

Description

Strides Pharma Science Ltd is into the development and manufacture of pharmaceutical products. The company has single segment Pharmaceutical. Pharmaceutical segment represents the business of development, manufacture and Commercialization of pharmaceutical products other than biological drugs. It has presence in North America, Australia, Africa, Europe, and India. The company generates majority of revenue from North America.

Contact Information

Website
www.strides.com
Formerly Known As
Strides Arcolab
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Strides House
  • Bilekahalli, Bannerghatta Road
  • Bangalore, 560076
  • India
+91 080678
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
NSE
Corporate Office
  • Strides House
  • Bilekahalli, Bannerghatta Road
  • Bangalore, 560076
  • India
+91 080678

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Strides Pharma Science Stock Performance

As of 19-Nov-2026, Strides Pharma Science’s stock price is $10.48. Its current market cap is $966M with 92.2M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.48 $10.25 $8.35 - $13.13 $966M 92.2M 349K $0.72

Strides Pharma Science Financials Summary

As of 30-Sep-2026, Strides Pharma Science has a trailing 12-month revenue of $562M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 1,240,861 1,066,066 943,398 1,141,125
Revenue 562,264 523,740 519,374 450,563
EBITDA 122,211 112,482 99,488 38,021
Net Income 66,524 62,944 424,973 (8,529)
Total Assets 779,669 734,186 707,128 700,265
Total Debt 198,318 186,321 219,739 301,806
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Strides Pharma Science Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Strides Pharma Science‘s full profile, request access.

Request a free trial

Strides Pharma Science Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Strides Pharma Science Ltd is into the development and manufacture of pharmaceutical products. The company has single se
Pharmaceuticals
Bangalore, India
4,050 As of 2026

Mumbai, India
 

Ahmedabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Strides Pharma Science Competitors (39)

One of Strides Pharma Science’s 39 competitors is Glenmark Pharmaceuticals, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Pharmaceuticals Corporation Mumbai, India
Zydus Lifesciences Corporation Ahmedabad, India
Beximco Pharmaceuticals Corporation Dhaka, Bangladesh
Dr. Reddy's Corporation Hyderabad, India
Alkem Laboratories Formerly PE-Backed Mumbai, India
You’re viewing 5 of 39 competitors. Get the full list »

Strides Pharma Science Patents

Strides Pharma Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026120644-A1 Soft gelatin capsules of acetaminophen and ibuprofen Pending 06-Dec-2024
AU-2019292334-A1 Lubrication unit and method of lubricating encapsulated soft gelatin capsule Active 26-Jun-2018
AU-2019292334-B2 Lubrication unit and method of lubricating encapsulated soft gelatin capsule Inactive 26-Jun-2018
US-20210259978-A1 Lubrication unit and method of lubricating encapsulated soft gelatin capsule Inactive 26-Jun-2018
WO-2020003326-A1 Lubrication unit and method of lubricating encapsulated soft gelatin capsule Inactive 26-Jun-2018 A61J3/07
To view Strides Pharma Science’s complete patent history, request access »

Strides Pharma Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Strides Pharma Science Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Strides Pharma Science‘s full profile, request access.

Request a free trial

Strides Pharma Science Investments & Acquisitions (55)

Strides Pharma Science’s most recent deal was a Corporate Asset Purchase with Sandoz (In-License Multiple Branded Generic Products in South Africa) for . The deal was made on 30-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sandoz (In-License Multiple Branded Generic Products in South Africa) 30-Jun-2026 Corporate Asset Purchase Buildings and Property
LMG Lasers 26-Jun-2026 Merger/Acquisition Surgical Devices
AMPIN Energy Transition 31-Dec-2025 Corporate Energy Production
Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) 29-Apr-2025 Corporate Asset Purchase Buildings and Property
Amexel 19-Mar-2025 Merger/Acquisition Other Commercial Services
You’re viewing 5 of 55 investments and acquisitions. Get the full list »

Strides Pharma Science ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

32.02 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Strides Pharma Science’s complete esg history, request access »

Strides Pharma Science Exits (11)

Strides Pharma Science’s most recent exit was on 19-Mar-2021 from OneSource Specialty Pharma. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
OneSource Specialty Pharma 19-Mar-2021 Completed
  • 5 buyers
Pharmapar 29-Jan-2019 Completed
Strides Chemicals 31-Dec-2016 Completed
Strides Shasun (probiotic business) 01-Dec-2015 Completed
Velbiom Probiotics 25-Nov-2015 Seed Round Completed
  • 2 buyers
You’re viewing 5 of 11 exits. Get the full list »

Strides Pharma Science Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Solara Active Pharma Sciences Chennai, India 2017
Fairmed Healthcare Zug, Switzerland 2012
Vensun Pharmaceuticals Yardley, PA 2011
Trinity Pharma Sandton, South Africa 2003
Beltapharm Cusano Milanino, Italy 1982
You’re viewing 5 of 6 affiliates. Get the full list.  »

Strides Pharma Science FAQs

  • When was Strides Pharma Science founded?

    Strides Pharma Science was founded in 1990.

  • Where is Strides Pharma Science headquartered?

    Strides Pharma Science is headquartered in Bangalore, India.

  • What is the size of Strides Pharma Science?

    Strides Pharma Science has 4,050 total employees.

  • What industry is Strides Pharma Science in?

    Strides Pharma Science’s primary industry is Pharmaceuticals.

  • Is Strides Pharma Science a private or public company?

    Strides Pharma Science is a Public company.

  • What is Strides Pharma Science’s stock symbol?

    The ticker symbol for Strides Pharma Science is STAR.

  • What is the current stock price of Strides Pharma Science?

    As of 19-Nov-2026 the stock price of Strides Pharma Science is $10.48.

  • What is the current market cap of Strides Pharma Science?

    The current market capitalization of Strides Pharma Science is $966M.

  • What is Strides Pharma Science’s current revenue?

    The trailing twelve month revenue for Strides Pharma Science is $562M.

  • Who are Strides Pharma Science’s competitors?

    Glenmark Pharmaceuticals, Zydus Lifesciences, Beximco Pharmaceuticals, Dr. Reddy's, and Alkem Laboratories are some of the 39 competitors of Strides Pharma Science.

  • What is Strides Pharma Science’s annual earnings per share (EPS)?

    Strides Pharma Science’s EPS for 12 months was $0.72.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process